12-6526591-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014865.4(NCAPD2):āc.2710A>Gā(p.Lys904Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014865.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCAPD2 | NM_014865.4 | c.2710A>G | p.Lys904Glu | missense_variant | 21/32 | ENST00000315579.10 | NP_055680.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCAPD2 | ENST00000315579.10 | c.2710A>G | p.Lys904Glu | missense_variant | 21/32 | 1 | NM_014865.4 | ENSP00000325017 | P1 | |
NCAPD2 | ENST00000382457.8 | c.2326A>G | p.Lys776Glu | missense_variant | 18/21 | 5 | ENSP00000371895 | |||
NCAPD2 | ENST00000542492.1 | n.643A>G | non_coding_transcript_exon_variant | 5/8 | 5 | |||||
NCAPD2 | ENST00000539084.5 | c.*2405A>G | 3_prime_UTR_variant, NMD_transcript_variant | 20/31 | 2 | ENSP00000438495 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461748Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 727144
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 29, 2024 | The c.2710A>G (p.K904E) alteration is located in exon 21 (coding exon 20) of the NCAPD2 gene. This alteration results from a A to G substitution at nucleotide position 2710, causing the lysine (K) at amino acid position 904 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at